Solvay/€SOLB

Solvay slides after reporting Q3 net sales down 6.8% and underlying EBITDA down 6.9% y/y and confirming FY25 EBITDA guidance of €880-930m.
15 hours agoLightyear AI
06:30
10:10
13:45
17:25
21:00
1D1W1MYTD1Y5YMAX

About Solvay

Solvay SA, listed under ticker SOLB, is a Belgium-based international chemical and advanced materials company. It operates through several business segments including Advanced Materials, Advanced Formulations, Performance Chemicals, and Corporate & Business Services. The company was founded in 1863 and has established itself as a key player in producing a wide range of products used in applications such as automotive, electronics, and healthcare.

Ticker

€SOLB
Sector

Primary listing

BSE

Employees

9,000

Solvay Metrics

BasicAdvanced
€2.7B
19.99
€1.31
0.66
€1.70
6.52%

What the Analysts think about Solvay

Analyst ratings (Buy, Hold, Sell) for Solvay stock.

Bulls say / Bears say

Free cash flow generation remains solid: H1 2025 FCF reached €97 million and Solvay confirms c. €300 million FCF guidance for 2025 alongside a net-debt/EBITDA leverage of 1.9×, supporting ongoing debt reduction (Solvay [turn0search0]).
The company’s cost-savings program targets €200 million by end-2025, up from €110 million in 2024, demonstrating strong operational discipline to offset inflation and support margins (Reuters [turn2news12]).
Solvay is expanding its rare-earth processing in La Rochelle to capture up to 30% of Europe’s neodymium/praseodymium demand for EV and wind-turbine magnets, positioning it to benefit from the energy transition megatrend (Reuters [turn1news12]).
H1 2025 net sales fell 4.8% organically and underlying EBITDA dropped 9.1% year-on-year, underscoring persistent demand weakness and margin pressure in key end markets (Solvay [turn0search0]).
In May 2025 Solvay revised its 2025 adjusted EBITDA guidance to the lower half of €1.0 billion–€1.1 billion, citing unfavorable market conditions and currency headwinds that highlight ongoing volatility (Reuters [turn0news13]).
Solvay’s leverage rose to a 1.9× net-debt/EBITDA ratio in Q2 2025 from 1.5× at end-2024, which may constrain financial flexibility for strategic investments or shareholder returns (Solvay [turn0search0]).
Data summarised monthly by Lightyear AI. Last updated on 5 Nov 2025.

Solvay Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

Solvay Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €SOLB

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs